drugset / Trial / NCT02170077
A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the efficacy of BIA 2 093 in the treatment of epileptic patients with refractory simple or complex partial seizures with or without secondary generalization.
Timeline
- Start
- 2002-04
- Primary completion
- 2002-11
- Completion
- 2002-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eslicarbazepine acetate | Unknown | 1200 mg | Oral |